active pharmaceutical ingredients

Trump’s Push for U.S. Drug Manufacturing Expands to Pharma Ingredients With New Executive Order

The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” The federal government will stockpile active pharmaceutical ingredients for these products, which the administration contends will insulate the U.S. from foreign supplies while also encouraging more domestic API production.

By Frank Vinluan

BioPharma

Sanofi creates new European pharmaceutical ingredient supplier

Although the move is designed to lower dependence on Asian suppliers, a spokesperson said it was not connected with the coronavirus outbreak, which according to a report Sunday has caused fears at the FDA that supplies of about 150 drugs could be at risk.

By Alaric DeArment